(Q38143316)

29 August 2017

Ovarian cancer: risk factors, treatment and management (English)

1 reference

29 August 2017

1 reference

Carolyn Rooth

1

1 reference

PubMed ID

24067270

29 August 2017

language of work or name

1 reference

1 September 2013

1 reference

British Journal of Nursing

29 August 2017

1 reference

29 August 2017

22

1 reference

29 August 2017

17

1 reference

29 August 2017

S23-30

1 reference

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

29 August 2017

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Identifying symptoms of ovarian cancer: a qualitative and quantitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Ovarian cancer and hormone replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Estimates of cancer incidence and mortality in Europe in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

The inherited genetics of ovarian and endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Development of an ovarian cancer symptom index: possibilities for earlier detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Population attributable fractions for ovarian cancer in Swedish women by morphological type

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Risk of ovarian cancer in women with symptoms in primary care: population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Does smoking increase risk of ovarian cancer? A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Histologic types of epithelial ovarian cancer: have they different risk factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Laparoscopy versus laparotomy for FIGO stage I ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

The pathology of and controversial aspects of ovarian borderline tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

History of the FIGO cancer staging system.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Reproductive factors for ovarian cancer in southern Chinese women

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Evolving concepts in the management of drug resistant ovarian cancer: dose dense chemotherapy and the reversal of clinical platinum resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

A qualitative study examining psychosocial distress, coping, and social support across the stages and phases of epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

The different etiologies of mucinous and nonmucinous epithelial ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Palliative and end-of-life care for patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Public awareness of cancer in Britain: a population-based survey of adults

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Venous thromboembolism in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Risk factors for ovarian cancer: an overview with emphasis on hormonal factors

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Current understanding of risk factors for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Ovarian cancer biomarkers for molecular biosensors and translational medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Ovarian cancer: the clinical role of US, CT, and MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Current status of gynecologic cancer in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2013.22.SUP17.S23

10.12968/BJON.2013.22.SUP17.S23

21 January 2018

Identifiers

DOI

0 references

PubMed ID

24067270

1 reference

PubMed ID

24067270